Top IVD Contract Manufacturing Companies

IVD Contract Manufacturing Market size was valued at USD 18.44 Billion in 2024 and is poised to grow from USD 20.57 Billion in 2025 to USD 49.51 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026–2033).

The global IVD contract manufacturing market is highly competitive, driven by a mix of established players, key service providers and emerging companies. Increasing demand for advanced diagnostic, regulatory solutions challenges and technological advances have shaped this competitive landscape. Companies compete based on their ability to offer innovative, cost-effective solutions while complying with stringent regulatory requirements. Jabil is a leading contract manufacturer in the market, offering a wide range of business services including manufacturing, assembly and compliance. 'Jabil Inc.  ', ' Sanmina Corporation  ', ' TE Connectivity  ', ' Celestica, Inc.  ', ' West Pharmaceutical Services, Inc.  ', ' Savyon Diagnostics, Ltd.  ', ' KMC Systems  ', ' Cenogenics Corporation  ', ' Nova Biomedical  ', ' Cone Bioproducts  ', ' Kimball Electronics, Inc.  ', 'Roche Diagnostics  ', ' Viant Medical Holdings, Inc.  ', 'Sysmex Corporation  ', ' Stratec Se  ', ' Thermo Fisher Scientific, Inc.  ', ' Fujirebio  ', ' Biokit (Werfen)  ', ' Sekisui  ', ' Prestige Diagnostics'

Increasing incidence of chronic diseases such as diabetes, cancer and heart disease is driving the need for advanced In Vitro Diagnostics (IVD) devices This demand has fueled the growth of the IVD contract manufacturing market, period whose manufacturers seek to increase productivity to address global health challenges. Contractors play a key role in providing cost-effective, quality solutions to IVD companies to help them meet rigorous regulatory standards.

Outsourcing to Emerging Markets: A developing trend inside the marketplace is outsourcing products to emerging markets, particularly in Asia-Pacific. Many groups are shifting to these regions due to the lower labor costs, increasing manufacturing strains and skilled personnel. This trend enables manufacturers to cut expenses and tap into the growing market.

North America, especially the US, is an important part of the IVD contract manufacturing market. The dominance of this segment can be attributed to advanced healthcare, well-established diagnostic companies and appropriate regulatory framework. Companies in North America are leading the adoption of cutting-edge technology with molecular diagnostics and personalized medicine along with atom, which significantly strengthens the market. North America emerged as the dominant region in the global IVD contract manufacturing market in 2023. North America boasts a well-developed healthcare infrastructure, including advanced medical facilities, research institutes and regulatory framework. The region is a hub for technological innovation and research in the health and life sciences industries.